About This Journal
Biologia Moderna is an open access that follows single-blind peer review policy. This journal invites authors to submit manuscripts in English by strictly adhering to the journal’s publication style mentioned in the author’s guidelines. The submitted manuscripts will be published after getting final approval from the editorial board.
Aims & Scope
The main objective of the journal is to cater to the academic and scholarly needs of the researchers, scholars, academicians, professionals and students by offering a competent forum for knowledge dissemination. Biologia Moderna focuses on diversified areas in this field including evolutionary biology, cell biology, molecular biology, Systems biology, Biomedicine, Cytokinebiology and Immunobiology.
Longdom a self-supporting publisher and does not receive funding from any institution/government. Hence, the operation of the journal is solely financed by the handling fees received from authors. Authors are required to make payment only after manuscript has been accepted for publication.
Manuscript TypeArticle Processing ChargesResearch or Other ArticlesUSDEuroGBP499468400
Membership and Reprints
Authors can take the benefits of membership and reprints of their article. For information about the membership and reprints of the journal and article respectively authors may contact to firstname.lastname@example.org or email@example.com
All content information of an accepted paper is strictly confidential and cannot appear in the media (in print or electronic form) before its embargo date and time. Authors/researchers, their respective public relations representatives and funding sponsors may not distribute or promote their work to the media prior to embargo.
If an embargo break is the result of any action by an author/researcher, he/she risks withdrawal of publication of his/her manuscript. Violations of the embargo policy may also jeopardize future acceptance of manuscripts to be published in the journal.
Generally, embargoes on journal articles lift the day and the time the article is published.
Although the Editorial Office will endeavor to notify authors of the anticipated publication date/time, it will not be responsible for any consequences of early online posting with regard to the intellectual property rights. To safeguard their intellectual property, authors should ensure that appropriate reports of invention and patent applications have been filed before the manuscript is accepted.
Requests for permission to reproduce figures, tables or portions of articles originally published in Biologia Moderna can be obtained via the Editorial Office.
Manuscripts submitted to Biologia Moderna should not contain material previously published in other publications, except as an abstract, and must not be currently under consideration for publication in another journal. Redundant publication is publication of a paper that overlaps substantially with one already published. When submitting a paper, authors should make a full statement to the editor about all submissions and previous reports that might be regarded as redundant publication of the same or similar work.
The authors should alert the editor if the work includes subjects about whom a previous report has been published. Copies of such material should be included with the submitted paper to help the editor decide how to handle the matter. If redundant publication is attempted without such notification, authors should expect editorial action to be taken; at the least, the manuscript will be rejected.
Authors and referees are asked to declare any competing interests.
Original Contributions submitted by the Editor-in-chief and any of the associate editors are handled by a Consulting Editor or by another editor, who makes all decisions about the manuscript (including choice of referees and ultimate acceptance or rejection).
The entire process is handled confidentially.
All manuscripts submitted from the Editor's home institution are also handled entirely by a Consulting Editor or by another editor from a different institution. The Editor (in Chief) and/or Associate Editors may additionally, from time to time, refer a manuscript to a Consulting Editor to avoid a real or reasonably perceived conflict of interest.
Ethics and Consent
Biologia Moderna considers research and publication misconduct to be a serious breach of ethics, and will take such actions as necessary to address such misconduct. Authors should refer to the Committee on Publication Ethics (COPE).
Statements, opinions and results of studies published in Biologia Moderna are those of the authors and do not reflect the policy or position of the journal.
Biologia Moderna provides no warranty as to the articles' accuracy or reliability.